[{"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "22.04", "Date_of_Payment": "05/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158845904", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "UCERIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "21.80", "Date_of_Payment": "09/03/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104004246", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xifaxan 550 mg", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "19.58", "Date_of_Payment": "09/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252774918", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "19.56", "Date_of_Payment": "04/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149715378", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NEXIUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "19.49", "Date_of_Payment": "05/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707032", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "19.39", "Date_of_Payment": "01/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295289004", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "19.04", "Date_of_Payment": "07/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "187552564", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "DELZICOL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "18.87", "Date_of_Payment": "04/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317235124", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "18.74", "Date_of_Payment": "04/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270352", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "18.69", "Date_of_Payment": "09/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "169216922", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "18.58", "Date_of_Payment": "07/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252773338", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "18.48", "Date_of_Payment": "10/17/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "31116712", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ferring Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000309", "Total_Amount_of_Payment_USDollars": "18.35", "Date_of_Payment": "04/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "192310516", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREPOPIK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ironwood Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000245", "Total_Amount_of_Payment_USDollars": "18.31", "Date_of_Payment": "07/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "324957926", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS 145 mcg", "Name_of_Associated_Covered_Drug_or_Biological2": "LINZESS 290 mcg", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "18.26", "Date_of_Payment": "08/27/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "103130306", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "18.20", "Date_of_Payment": "11/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252777400", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "18.12", "Date_of_Payment": "03/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148792730", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NEXIUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.93", "Date_of_Payment": "09/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "31116711", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.89", "Date_of_Payment": "10/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189551470", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Moderiba", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "17.88", "Date_of_Payment": "02/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260215246", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "17.78", "Date_of_Payment": "03/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707028", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "17.76", "Date_of_Payment": "11/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "170107202", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "17.70", "Date_of_Payment": "03/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "299223164", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "17.61", "Date_of_Payment": "05/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270356", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.59", "Date_of_Payment": "11/18/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "316962668", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.57", "Date_of_Payment": "11/28/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "31116708", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.48", "Date_of_Payment": "03/13/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189213688", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "17.33", "Date_of_Payment": "06/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270360", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "17.25", "Date_of_Payment": "12/16/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "326490358", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Covered-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "17.10", "Date_of_Payment": "07/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189423648", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "17.03", "Date_of_Payment": "09/24/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "103319756", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Dexilant", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "16.92", "Date_of_Payment": "09/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158893172", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SOLESTA", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "16.92", "Date_of_Payment": "03/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317260006", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "16.80", "Date_of_Payment": "05/06/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "170107200", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "16.76", "Date_of_Payment": "07/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300746340", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "16.70", "Date_of_Payment": "01/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260209462", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "16.65", "Date_of_Payment": "01/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158650724", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "16.64", "Date_of_Payment": "10/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317235262", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Viekira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "16.61", "Date_of_Payment": "10/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317254754", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "16.58", "Date_of_Payment": "02/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707044", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi Aria", "Name_of_Associated_Covered_Drug_or_Biological2": "Remicade", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "16.55", "Date_of_Payment": "08/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300746354", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "16.42", "Date_of_Payment": "07/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270368", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "16.35", "Date_of_Payment": "03/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149655268", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "16.24", "Date_of_Payment": "01/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317168384", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "16.22", "Date_of_Payment": "06/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337212214", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Dexilant", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "16.18", "Date_of_Payment": "09/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317182042", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "16.17", "Date_of_Payment": "08/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707036", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "16.02", "Date_of_Payment": "08/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "187552566", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "DELZICOL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "16.01", "Date_of_Payment": "09/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158705132", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "15.87", "Date_of_Payment": "02/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "148517372", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NEXIUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.62", "Date_of_Payment": "12/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317009480", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ironwood Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000245", "Total_Amount_of_Payment_USDollars": "15.60", "Date_of_Payment": "08/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "191621254", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS 145 mcg", "Name_of_Associated_Covered_Drug_or_Biological2": "LINZESS 290 mcg", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.56", "Date_of_Payment": "09/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189519914", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "15.52", "Date_of_Payment": "02/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252767400", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "15.46", "Date_of_Payment": "11/19/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158850334", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "15.41", "Date_of_Payment": "04/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707030", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "15.31", "Date_of_Payment": "07/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300746346", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "15.28", "Date_of_Payment": "10/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270340", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "REMICADE", "Name_of_Associated_Covered_Drug_or_Biological2": "SIMPONI", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.24", "Date_of_Payment": "08/06/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "31116710", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "15.21", "Date_of_Payment": "10/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252776094", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "15.19", "Date_of_Payment": "09/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149674434", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.13", "Date_of_Payment": "10/08/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "31116707", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.13", "Date_of_Payment": "11/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "31116709", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire US Holdings", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000241", "Total_Amount_of_Payment_USDollars": "15.10", "Date_of_Payment": "10/08/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "6385240", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "15.09", "Date_of_Payment": "08/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189463932", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "15.03", "Date_of_Payment": "01/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149571260", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NEXIUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "14.85", "Date_of_Payment": "04/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295289024", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN - 550MG", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "14.82", "Date_of_Payment": "08/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158702380", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "14.75", "Date_of_Payment": "08/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189442184", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "14.69", "Date_of_Payment": "07/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "169216920", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "14.67", "Date_of_Payment": "08/14/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23870420", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "14.63", "Date_of_Payment": "09/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337334440", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "14.62", "Date_of_Payment": "02/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339475084", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "DELZICOL", "Name_of_Associated_Covered_Drug_or_Biological2": "ASACOL HD", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "14.59", "Date_of_Payment": "12/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "169216924", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "14.59", "Date_of_Payment": "08/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317392624", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "14.49", "Date_of_Payment": "11/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270337", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "REMICADE", "Name_of_Associated_Covered_Drug_or_Biological2": "SIMPONI", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "14.43", "Date_of_Payment": "12/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252778466", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "14.38", "Date_of_Payment": "08/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260195872", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "14.34", "Date_of_Payment": "08/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149671368", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "14.27", "Date_of_Payment": "12/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149683310", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "14.27", "Date_of_Payment": "11/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339454544", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "14.27", "Date_of_Payment": "11/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339454548", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "14.21", "Date_of_Payment": "05/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189335792", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "14.16", "Date_of_Payment": "12/23/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23870424", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "Olysio", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "14.01", "Date_of_Payment": "10/13/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149677964", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "14.00", "Date_of_Payment": "04/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300396650", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "13.99", "Date_of_Payment": "04/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "170107198", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "13.99", "Date_of_Payment": "04/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295289018", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN - 550MG", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Gilead Sciences Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000108", "Total_Amount_of_Payment_USDollars": "13.87", "Date_of_Payment": "10/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "168808242", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "724598-1821692-8032620 - 1633695 - 21070528-1633695-Gilead Sciences-VRL"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "13.75", "Date_of_Payment": "07/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317234452", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ironwood Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000245", "Total_Amount_of_Payment_USDollars": "13.73", "Date_of_Payment": "04/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "324941672", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS 145 mcg", "Name_of_Associated_Covered_Drug_or_Biological2": "LINZESS 290 mcg", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "13.71", "Date_of_Payment": "09/10/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "23870422", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "13.71", "Date_of_Payment": "09/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707038", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "13.71", "Date_of_Payment": "08/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252774002", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "13.69", "Date_of_Payment": "06/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339420550", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "13.66", "Date_of_Payment": "05/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "300396676", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "13.65", "Date_of_Payment": "04/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260191426", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire US Holdings", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000241", "Total_Amount_of_Payment_USDollars": "13.57", "Date_of_Payment": "11/05/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "6385241", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "13.55", "Date_of_Payment": "01/26/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "308632678", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "13.53", "Date_of_Payment": "11/06/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "100480004", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "13.51", "Date_of_Payment": "07/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337267760", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Cook Incorporated", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IN", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010458", "Total_Amount_of_Payment_USDollars": "13.48", "Date_of_Payment": "07/03/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "211346802", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Physicians are provided modest meals during the course of doing business with Cook Medical. The physician could be attending or presenting at an educational presentation or a product training session. We also invite physicians to dinners to give us feedback on our products or to advise us on trends in medical procedures and treatments. The total cost of a group's food and beverages at a meal are averaged across attendees."}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "13.45", "Date_of_Payment": "02/19/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473786", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "13.44", "Date_of_Payment": "02/24/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "308902790", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "13.39", "Date_of_Payment": "11/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260189946", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "13.35", "Date_of_Payment": "11/07/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "12120476", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NEXIUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "13.33", "Date_of_Payment": "09/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473804", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "13.33", "Date_of_Payment": "06/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339399316", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "13.31", "Date_of_Payment": "04/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194621386", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "13.18", "Date_of_Payment": "12/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270344", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "REMICADE", "Name_of_Associated_Covered_Drug_or_Biological2": "SIMPONI", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "FOREST PHARMACEUTICALS, INC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005529", "Total_Amount_of_Payment_USDollars": "13.12", "Date_of_Payment": "07/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "147948482", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "13.09", "Date_of_Payment": "12/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158553248", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ironwood Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000245", "Total_Amount_of_Payment_USDollars": "13.09", "Date_of_Payment": "02/27/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "191621248", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS 145 mcg", "Name_of_Associated_Covered_Drug_or_Biological2": "LINZESS 290 mcg", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "13.09", "Date_of_Payment": "01/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295289000", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN - 550MG", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "13.04", "Date_of_Payment": "09/25/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "103130308", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "12.90", "Date_of_Payment": "08/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "316964190", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.87", "Date_of_Payment": "01/07/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270326", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OLYSIO", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "12.84", "Date_of_Payment": "05/29/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189344072", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.78", "Date_of_Payment": "07/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270364", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "12.74", "Date_of_Payment": "01/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252766012", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "12.70", "Date_of_Payment": "03/18/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189220334", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "12.67", "Date_of_Payment": "10/22/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "12105574", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NEXIUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.64", "Date_of_Payment": "11/30/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270332", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "REMICADE", "Name_of_Associated_Covered_Drug_or_Biological2": "SIMPONI", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ironwood Pharmaceuticals, Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000245", "Total_Amount_of_Payment_USDollars": "12.60", "Date_of_Payment": "12/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "191621256", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS 145 mcg", "Name_of_Associated_Covered_Drug_or_Biological2": "LINZESS 290 mcg", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "12.59", "Date_of_Payment": "12/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "301177578", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.48", "Date_of_Payment": "03/25/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707046", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi Aria", "Name_of_Associated_Covered_Drug_or_Biological2": "Remicade", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "12.42", "Date_of_Payment": "04/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252769450", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "12.41", "Date_of_Payment": "01/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "309347047", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "12.36", "Date_of_Payment": "06/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158611050", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "12.34", "Date_of_Payment": "01/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339341522", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "12.33", "Date_of_Payment": "07/28/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260183742", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.31", "Date_of_Payment": "07/31/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707034", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "OLYSIO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "12.31", "Date_of_Payment": "01/08/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473784", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "12.29", "Date_of_Payment": "05/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158643278", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "12.22", "Date_of_Payment": "12/17/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707022", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Olysio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "12.18", "Date_of_Payment": "01/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "336825794", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "12.16", "Date_of_Payment": "10/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473806", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "12.15", "Date_of_Payment": "03/25/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252768742", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "11.75", "Date_of_Payment": "04/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158663344", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "UCERIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "11.75", "Date_of_Payment": "12/14/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260180788", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "11.72", "Date_of_Payment": "07/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473800", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "11.60", "Date_of_Payment": "02/05/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295289014", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "11.46", "Date_of_Payment": "05/19/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260178406", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "11.44", "Date_of_Payment": "03/14/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473788", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "11.40", "Date_of_Payment": "08/20/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270372", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "11.40", "Date_of_Payment": "10/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "301177571", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "11.37", "Date_of_Payment": "11/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158584112", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "11.33", "Date_of_Payment": "11/29/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "104009908", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Xifaxan 550 mg", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "11.32", "Date_of_Payment": "05/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "149175256", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NEXIUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "11.30", "Date_of_Payment": "07/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339241506", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "DELZICOL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Braintree Laboratories, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000153", "Total_Amount_of_Payment_USDollars": "11.28", "Date_of_Payment": "05/12/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "252770560", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "SUPREP", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "11.22", "Date_of_Payment": "11/20/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "219486964", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Lotronex", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "11.13", "Date_of_Payment": "04/22/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "326471748", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Covered-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "11.13", "Date_of_Payment": "04/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337094144", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "11.12", "Date_of_Payment": "01/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "295289008", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "BUDESONIDE FOAM", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "11.11", "Date_of_Payment": "12/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473810", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ferring Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000309", "Total_Amount_of_Payment_USDollars": "11.05", "Date_of_Payment": "10/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "192310524", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREPOPIK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "11.00", "Date_of_Payment": "10/23/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "219499916", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Lotronex", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "10.95", "Date_of_Payment": "07/02/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "219493272", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Lotronex", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "10.83", "Date_of_Payment": "04/16/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473790", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "10.69", "Date_of_Payment": "08/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270376", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "10.64", "Date_of_Payment": "10/27/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "326482610", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Non-Covered-Product", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "10.63", "Date_of_Payment": "05/14/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473792", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Ferring Pharmaceuticals Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000309", "Total_Amount_of_Payment_USDollars": "10.53", "Date_of_Payment": "12/12/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21676381", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "PREPOPIK", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "10.52", "Date_of_Payment": "06/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189353814", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "10.48", "Date_of_Payment": "12/17/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317063708", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Prometheus Laboratories Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010425", "Total_Amount_of_Payment_USDollars": "10.43", "Date_of_Payment": "09/08/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "219490372", "Nature_of_Payment_or_Transfer_of_Value": "Education", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Lotronex", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AstraZeneca Pharmaceuticals LP", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "DE", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000146", "Total_Amount_of_Payment_USDollars": "10.40", "Date_of_Payment": "07/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "150189656", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "NEXIUM", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": "Informational Meal"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "10.39", "Date_of_Payment": "08/26/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189472114", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Genentech USA, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000226", "Total_Amount_of_Payment_USDollars": "10.30", "Date_of_Payment": "11/21/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "29784721", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Pegasys", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "10.19", "Date_of_Payment": "01/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189149018", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Humira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "UCB, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "GA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000073", "Total_Amount_of_Payment_USDollars": "10.19", "Date_of_Payment": "07/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "260167590", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Cimzia", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "10.17", "Date_of_Payment": "06/30/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158811556", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "10.15", "Date_of_Payment": "02/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270330", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "OLYSIO", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "10.06", "Date_of_Payment": "01/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707040", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi Aria", "Name_of_Associated_Covered_Drug_or_Biological2": "Remicade", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "10.04", "Date_of_Payment": "05/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194621393", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "9.95", "Date_of_Payment": "11/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194621402", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "9.91", "Date_of_Payment": "10/20/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "194621398", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "9.88", "Date_of_Payment": "10/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158889810", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "9.84", "Date_of_Payment": "02/23/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337023040", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Given Imaging, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000348", "Total_Amount_of_Payment_USDollars": "9.45", "Date_of_Payment": "09/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "325026678", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "8.97", "Date_of_Payment": "02/09/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339107038", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LINZESS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "8.93", "Date_of_Payment": "03/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158584848", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "UCERIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Given Imaging, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "CT", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000348", "Total_Amount_of_Payment_USDollars": "8.89", "Date_of_Payment": "09/15/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "325026686", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "8.83", "Date_of_Payment": "08/07/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "103319750", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "7.81", "Date_of_Payment": "03/04/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270380", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi", "Name_of_Associated_Covered_Drug_or_Biological2": "Remicade", "Contextual_Information": "Related to product discussion"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "7.78", "Date_of_Payment": "12/03/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "270270348", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": "Related to bona-fide consulting activity"}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Actavis Pharma Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NJ", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010642", "Total_Amount_of_Payment_USDollars": "7.36", "Date_of_Payment": "06/29/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "339060984", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "DELZICOL", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "6.49", "Date_of_Payment": "09/21/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "317128872", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Viekira", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "6.23", "Date_of_Payment": "06/09/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707024", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "5.01", "Date_of_Payment": "03/11/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302178278", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "4.76", "Date_of_Payment": "10/16/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "103319752", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "4.40", "Date_of_Payment": "05/13/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302188950", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "4.39", "Date_of_Payment": "10/06/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302212876", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "3.60", "Date_of_Payment": "05/14/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473794", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "1.70", "Date_of_Payment": "10/15/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "103319754", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Amitiza", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.93", "Date_of_Payment": "07/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473796", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "AbbVie, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000204", "Total_Amount_of_Payment_USDollars": "0.84", "Date_of_Payment": "05/22/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "189335790", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Creon", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.83", "Date_of_Payment": "07/01/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302196566", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.69", "Date_of_Payment": "04/08/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302183054", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.61", "Date_of_Payment": "08/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158691938", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "UCERIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.60", "Date_of_Payment": "12/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158781240", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.59", "Date_of_Payment": "07/10/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473798", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.59", "Date_of_Payment": "09/03/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473802", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.55", "Date_of_Payment": "10/01/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "136473808", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.52", "Date_of_Payment": "05/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158660636", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.48", "Date_of_Payment": "11/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158574392", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Shire North American Group Inc", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "MA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000061292", "Total_Amount_of_Payment_USDollars": "0.47", "Date_of_Payment": "11/10/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "302221634", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "LIALDA", "Name_of_Associated_Covered_Drug_or_Biological2": "PENTASA", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.45", "Date_of_Payment": "01/28/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158650730", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "APRISO", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Takeda Pharmaceuticals America, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000339", "Total_Amount_of_Payment_USDollars": "0.44", "Date_of_Payment": "09/02/2015", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "337334458", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Entyvio", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "0.43", "Date_of_Payment": "06/11/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707026", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Remicade", "Name_of_Associated_Covered_Drug_or_Biological2": "Simponi", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.41", "Date_of_Payment": "03/05/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158610477", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "UCERIS", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.40", "Date_of_Payment": "09/02/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158678662", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "APRISO", "Name_of_Associated_Covered_Drug_or_Biological2": "XIFAXAN 550 MG TABLETS", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Janssen Biotech, Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000329", "Total_Amount_of_Payment_USDollars": "0.38", "Date_of_Payment": "01/07/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "156707042", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "Simponi Aria", "Name_of_Associated_Covered_Drug_or_Biological2": "Remicade", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.32", "Date_of_Payment": "06/04/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158617446", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "UCERIS", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Contextual_Information": ""}, {"Physician_Profile_ID": "284972", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Salix Pharmaceuticals, Ltd", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000010796", "Total_Amount_of_Payment_USDollars": "0.31", "Date_of_Payment": "04/21/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "158547586", "Nature_of_Payment_or_Transfer_of_Value": "Food and Beverage", "Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value": "", "Name_of_Associated_Covered_Drug_or_Biological1": "XIFAXAN 550 MG TABLETS", "Name_of_Associated_Covered_Drug_or_Biological2": "UCERIS", "Contextual_Information": ""}]